AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+16.3%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$5.04B
AUM Growth
+$5.04B
(+12%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
92.8%
Holding
109
New
12
Increased
18
Reduced
24
Closed
12
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$7.42M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$6.77M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$6.21M |
| 4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$5.6M |
| 5 |
ProQR Therapeutics
PRQR
|
$4.85M |
Top Sells
| 1 |
Goldman Sachs
GS
|
$22.2M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$18.1M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$16.7M |
| 4 |
BLUE
bluebird bio
BLUE
|
$15.8M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
Sector Composition
| 1 | Consumer Staples | 49.27% |
| 2 | Consumer Discretionary | 25.43% |
| 3 | Healthcare | 24.54% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BUFF
1
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $2.48B | 42.71% | 87,460,875 | – | – |
|
|
WW
2
DELISTED
WW International
WW
| $1.28B | 22.09% | 29,443,300 | – | – |
|
3
Lexicon Pharmaceuticals
LXRX
$400M
| $707M | 12.18% | 57,517,977 | – | – |
|
4
Incyte
INCY
$16.5B
| $46.7M | 0.8% | 400,000 | – | – |
|
|
5
Agios Pharmaceuticals
AGIO
$2.19B
| $30M | 0.52% | 450,000 -250,000 | -36% | -$16.7M |
|
6
Nektar Therapeutics
NKTR
$568M
| $30M | 0.52% | 1,250,000 -150,000 | -11% | -$3.6M |
|
7
Alnylam Pharmaceuticals
ALNY
$58.5B
| $29.4M | 0.51% | 250,000 -25,000 | -9% | -$2.94M |
|
|
XLRN
8
DELISTED
Acceleron Pharma Inc.
XLRN
| $26.1M | 0.45% | 700,000 | – | – |
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $24.5M | 0.42% | 400,000 -150,000 | -27% | -$9.19M |
|
|
ONC
10
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $23.3M | 0.4% | 225,000 -175,000 | -44% | -$18.1M |
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $18.6M | 0.32% | 200,000 -50,000 | -20% | -$4.65M |
|
|
BLUE
12
DELISTED
bluebird bio
BLUE
| $18.5M | 0.32% | 135,000 -115,000 | -46% | -$15.8M |
|
|
ARRY
13
DELISTED
Array Biopharma Inc
ARRY
| $18.5M | 0.32% | 1,500,000 +550,000 | +58% | +$6.77M |
|
14
Ironwood Pharmaceuticals
IRWD
$214M
| $12.9M | 0.22% | 816,879 +200,000 | +32% | +$3.15M |
|
|
AVXS
15
DELISTED
AveXis, Inc. Common Stock
AVXS
| $11.6M | 0.2% | 120,000 -20,000 | -14% | -$1.93M |
|
|
RXDX
16
DELISTED
Ignyta, Inc.
RXDX
| $11.1M | 0.19% | 900,000 | – | – |
|
|
MDCO
17
DELISTED
Medicines Co
MDCO
| $11.1M | 0.19% | 300,000 -50,000 | -14% | -$1.85M |
|
|
AGEN
18
Agenus
AGEN
$133M
| $11M | 0.19% | 2,500,000 +500,000 | +25% | +$2.21M |
|
19
Amicus Therapeutics
FOLD
$2.34B
| $10.6M | 0.18% | 700,000 -700,000 | -50% | -$10.6M |
|
20
Atara Biotherapeutics
ATRA
$84.6M
| $9.93M | 0.17% | 600,000 +100,000 | +20% | +$1.66M |
|
|
TSRO
21
DELISTED
TESARO, Inc.
TSRO
| $9.68M | 0.17% | 75,000 +25,000 | +50% | +$3.23M |
|
|
RDUS
22
DELISTED
Radius Health, Inc.
RDUS
| $9.64M | 0.17% | 250,000 +100,000 | +67% | +$3.86M |
|
|
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
| $9.48M | 0.16% | 115,000 +90,000 | +360% | +$7.42M |
|
|
SAGE
24
DELISTED
Sage Therapeutics
SAGE
| $9.35M | 0.16% | 150,000 +60,000 | +67% | +$3.74M |
|
|
GBT
25
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $9.32M | 0.16% | 300,000 +200,000 | +200% | +$6.21M |
|